Ağrının Doku Düzeyindeki Yansımaları: Histopatolojik Bir Çerçeve
Özet
Ağrı, yalnızca sinir sistemi tarafından oluşturulan duyusal bir deneyim değil, doku mikroçevresinde gelişen inflamatuvar, vasküler, hücresel ve stromal değişikliklerin bütüncül bir sonucudur. Bu bölümde ağrının doku düzeyindeki histopatolojik yansımaları; akut ve kronik inflamasyon, ödem, vasküler değişiklikler, hücresel dejenerasyon, nekroz, fibrozis ve ekstrasellüler matriks yeniden yapılanması çerçevesinde ele alınmaktadır. Proinflamatuvar sitokinler, prostaglandinler, kininler, nöropeptidler ve matriks metalloproteinazlar gibi mediyatörlerin nosiseptör aktivasyonu, periferik sensitizasyon ve ağrının kronikleşmesindeki rolleri değerlendirilmektedir. Ayrıca sinir lifleri, mast hücreleri, makrofajlar ve diğer immün hücreler arasındaki çift yönlü iletişim üzerinden gelişen nöro-immün etkileşimlerin histopatolojik karşılıkları açıklanmaktadır. Sonuç olarak histopatolojik inceleme, ağrının morfolojik temelini ortaya koymanın yanı sıra patofizyolojik mekanizmaların anlaşılmasına, biyobelirteçlerin belirlenmesine ve hedefe yönelik tedavi yaklaşımlarının geliştirilmesine katkı sağlayan temel bir yöntemdir.
Pain is not merely a sensory experience generated by the nervous system but an integrated consequence of inflammatory, vascular, cellular, and stromal alterations within the tissue microenvironment. This chapter examines the histopathological manifestations of pain in the context of acute and chronic inflammation, edema, vascular alterations, cellular degeneration, necrosis, fibrosis, and extracellular matrix remodeling. The roles of proinflammatory cytokines, prostaglandins, kinins, neuropeptides, and matrix metalloproteinases in nociceptor activation, peripheral sensitization, and pain chronification are discussed. Particular emphasis is placed on the histopathological consequences of bidirectional neuro-immune interactions involving nerve fibers, mast cells, macrophages, and other immune cells. Overall, histopathological examination not only reveals the morphological basis of pain but also contributes to understanding its underlying pathophysiological mechanisms, identifying potential biomarkers, and developing targeted therapeutic strategies.
Referanslar
Schaible HG, Straub RH. Pain neurophysiology. In: Watts RA, et al. (eds.) Oxford Textbook of Rheumatology. 4th ed. Oxford: Oxford University Press; 2013.
Çoban E. Hastalıkların patofizyolojisi. Ankara: Palme Yayıncılık; 2021.
Zhang A, Lee YC. Mechanisms for joint pain in rheumatoid arthritis: from cytokines to central sensitization. Current Osteoporosis Reports. 2018;16(5): 603-610.
Zhang S, Ning Y, Yang Y, ve ark. Decoding pain chronification: mechanisms of the acute-to-chronic transition. Frontiers in Molecular Neuroscience. 2025;18: 1596367.
Nijs J, George SZ, Clauw DJ, ve ark. Central sensitisation in chronic pain conditions. The Lancet Rheumatology. 2021;3(5): 383-392.
Fang XX, Zhai MN, Zhu M, ve ark. Inflammation in pathogenesis of chronic pain. Molecular Pain. 2023;19: 17448069231178176.
Hannoodee S, Nasuruddin DN. Acute inflammatory response. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
Pahwa R, Goyal A, Jialal I. Chronic inflammation. In: StatPearls. 2025.
Kumar V, Abbas AK, Aster JC. Robbins & Cotran Pathologic Basis of Disease. 11th ed. Philadelphia: Elsevier; 2025.
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288: 1765-1769.
Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response. Annual Review of Neuroscience. 2009;32: 1-32.
Kidd BL, Urban LA. Mechanisms of inflammatory pain. British Journal of Anaesthesia. 2001;87(1): 3-11.
Wynn TA. Cellular and molecular mechanisms of fibrosis. The Journal of Pathology. 2008;214(2): 199-210.
Basbaum AI, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2): 267-284.
Kalliolias GD, Ivashkiv LB. TNF biology and pathogenic mechanisms. Nature Reviews Rheumatology. 2016;12(1): 49-62.
Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011;31(5): 986-1000.
Gregory NS, Harris AL, Robinson CR, ve ark. Animal models of pain. The Journal of Pain. 2013;14(11): 1255-1269.
Hunskaar S, Hole K. The formalin test in mice. Pain. 1987;30(1): 103-114.
Dubuisson D, Dennis SG. Formalin test analgesia study. Pain. 1977;4(2): 161-174.
Abbadie C, Taylor BK, Peterson MA, ve ark. Formalin c-fos study. Pain. 1997;69(1-2): 101-110.
Winter CA, Risley EA, Nuss GW. Carrageenan-induced edema. Proceedings of the Society for Experimental Biology and Medicine. 1962;111: 544-547.
Morris CJ. Carrageenan-induced paw edema. Methods in Molecular Biology. 2003;225: 115-121.
Guay J, Bateman K, Gordon R, ve ark. PGE2 response in carrageenan model. Journal of Biological Chemistry. 2004;279(23): 24866-24872.
Burek DJ, Massaly N, Yoon HJ, ve ark. CFA inflammatory pain model. Pain. 2022;163(5): 809-819.
Du JY, Fang JQ, Liang Y, ve ark. CFA and JNK pathway. Brain Research Bulletin. 2014;108: 27-36.
Bennett GJ, Xie YK. CCI modeli. Pain. 1988;33(1): 87-107.
Decosterd I, Woolf CJ. SNI modeli. Pain. 2000;87(2): 149-158.
Wang LX, Wang ZJ. Chronic pain models. Advanced Drug Delivery Reviews. 2003;55(8): 949-965.
Shubayev VI, Myers RR. TNF neuropathy. Journal of the Peripheral Nervous System. 2002;7(1): 28-36.
Ji RR, Nackley A, Huh Y, ve ark. Neuroinflammation and central sensitization. Anesthesiology. 2018;129(2): 343-366.
Calvo M, Dawes JM, Bennett DL. Immune system in neuropathic pain. The Lancet Neurology. 2012;11(7): 629-642.
Woolf CJ. Central sensitization implications. Pain. 2011;152(Suppl 3): S2-S15.
